---
figid: PMC11019011__fphar-15-1370900-g006
pmcid: PMC11019011
image_filename: fphar-15-1370900-g006.jpg
figure_link: /pmc/articles/PMC11019011/figure/F6/
number: FIGURE 6
figure_title: ''
caption: Role of the RANK/NF-κB (RANKL)/OPG signaling pathway in osteoporosis. Nuclear
  factor-κB, NF-κB; nuclear factor kappa B, RANK; nuclear factor-κB ligand, RANKL;
  inhibitor of NF-κB α, IκBα; osteoprotegerin, OPG; interleukin, IL; glycogen synthase
  kinase-3β, GSK-3β; nuclear factor of activated T-cells 1, NFATC1; forkhead box O,
  FoxO; reactive oxygen species, ROS; and macrophage colony-stimulating factor, MCSF.
article_title: 'Traditional Chinese medicine in osteoporosis: from pathogenesis to
  potential activity.'
citation: Gang Cao, et al. Front Pharmacol. 2024;15:1370900.
year: '2024'

doi: 10.3389/fphar.2024.1370900
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- osteoporosis
- pathogenesis
- pathogenic factors
- traditional Chinese medicine
- treatment

---
